Segall Bryant & Hamill’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Segall Bryant & Hamill’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-8,940	Closed	-$735K	–	857
2019 Q4	$735K	Buy	8,940 +3	+0%	+$210	0.01%	588
2019 Q3	$764K	Buy	8,937 +1,534	+21%	+$164K	0.01%	569
2019 Q2	$944K	Buy	7,403 +1,677	+29%	+$242K	0.01%	542
2019 Q1	$1.03M	Sell	5,726 -1,018	-15%	-$147K	0.02%	526
2018 Q4	$749K	Buy	6,744 +1,428	+27%	+$186K	0.01%	573
2018 Q3	$718K	Buy	5,316 +1,105	+26%	+$152K	0.01%	611
2018 Q2	$581K	Buy	+4,211	New	+$579K	0.01%	646

Other funds holding SRGA

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

CLG

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Segall Bryant & Hamill's SRGA Position: Q1 2020 in Review

Segall Bryant & Hamill sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q1 2020, closing a stake of 8,940 shares — an estimated $735K sold.

Segall Bryant & Hamill first reported a position in SRGA in Q2 2018 and held it in 7 quarters. The position peaked at $1.03M in Q1 2019. 83 funds tracked by Wall St. Rank hold SRGA as of Q1 2020.

Segall Bryant & Hamill reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Segall Bryant & Hamill sold 8,940 Surgalign Holdings, Inc. Common Stock shares in Q1 2020, an estimated $735K.
Segall Bryant & Hamill first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2018 and held it in 7 quarters.
Segall Bryant & Hamill's Surgalign Holdings, Inc. Common Stock position peaked at $1.03M in Q1 2019.
83 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q1 2020.

Based on Segall Bryant & Hamill's 13F filing for Q1 2020, filed 14 May 2020.